To keep a stable therapeutic level of cyclosporine during the early posttransplant period is important in graft survival
Ahn, M.S.; Ha, J.; Yun, I.J.; Kim, S.; Lee, J.S.; Kim, S.; Han, J.S.; Ahn, C.; Choi, Y.; Cheong, H.I.; Kim, S.T.; Kim, S.J.
Transplantation Proceedings 28(3): 1316-1317
1996
ISSN/ISBN: 0041-1345 PMID: 8658675 Document Number: 468076
Document emailed within 1 workday
Related Documents
Awni, W.M.; Kasiske, B.; Heim-Duthoy, K.; Rose, M.; Rao, V.K.; Bloom, P.; Ney, A.; Andrisevic, J.; Odland, M.; Andersen, R.C. 1988: Changes in the pharmacokinetics of cyclosporine and three of its metabolites in renal transplant patients early in the posttransplant period Transplantation Proceedings 20(2 Suppl. 2): 623-624Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181
Gray, J.R.; Kasiske, B.L. 1992: Patient and renal allograft survival in the late posttransplant period Seminars in Nephrology 12(4): 343-352
Barber, W.H.; Hudson, S.L.; Deierhoi, M.H.; Laskow, D.A.; Diethelm, A.G. 1990: Pulsatile perfusion preservation: early posttransplant dialysis requirement predicts rapid graft loss Transplantation Proceedings 22(2): 446-447
Simpson, M.A.; Madras, P.N.; Crosson, A.W.; Georgi, B.A.; Monaco, A.P. 1987: Correlation of binding of human immunoglobulin, urinary cytology, and needle biopsy in the early posttransplant period Transplantation Proceedings 19(1 Part 2): 1662-1663
Mirisklavos, A.; Mottram, P.L.; Smith, J.A.; Mason, A.; Dumble, L.J.; Clunie, G.J.; Panagiotopoulos, S.; Nayler, W.G. 1987: Cyclosporine A: graft survival and cardiotoxicity in murine cardiac allografts Transplantation Proceedings 19(1 Part 2): 1259-1261
Pappalettera, M.; Pizzi, C.; Cardillo, M.; Piccolo, G.; Aniasi, A.; Lecchi, L.; Poli, F.; Sirchia, G. 1994: Factors influencing cadaver kidney graft survival in two cyclosporine periods Transplantation Proceedings 26(5): 2533-2534
Parikh, Y.; Toledo-Pereyra, L.H.; Finkelstein, I.; Bandlien, K.; Castellanos, J.; Mittal, V. 1987: Prolonged pancreas transplant survival following graft donor pretreatment with cyclosporine a or concanavalin a Transplantation Proceedings 19(5): 4336-4339
Opelz, G.; Schwarz, V.; Engelmann, A.; Back, D.; Wilk, M.; Keppel, E. 1991: Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients Transplantation Proceedings 23(1 Part 1): 373-375
Goto, S.; Kim, Y.I.; Moore, T.D.; Pillay, S.P.; Kamada, N. 1993: Graft survival in rats following extended cold preservation was improved with recipient pretransplant cyclosporine therapy Transplantation Proceedings 25(5): 2906
Hourmant, M.; Buzelin, F.; Dubigeon, P.; Soulillou, J.P. 1987: High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy Transplantation Proceedings 19(1 Pt 3): 2113-2114
Rolles, K.; Calne, R.Y. 1986: Cyclosporine in the first month posttransplant Transplantation Proceedings 18(2 Suppl 1: 55-58
Stula, N. 1992: Adjuvant cytostatic therapy of breast cancer as an important factor in the postponing of a relapse and longer survival period Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 46(2): 101-111
Hoshino, Y.; Suzuki, C.; Ohtsuki, M.; Masubuchi, Y.; Amano, Y.; Chiba, K. 1996: FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine a Transplantation Proceedings 28(2): 1060-1061
Tegzess, A.M.; van Son, W.J.; de Maar, E.F.; Beelen, J.M.; Sluiter, W.J.; Huisman, R.M. 1989: Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function Transplantation Proceedings 21(1 Part 2): 1635-1637
Hull, A.R.; Atkins, C.R.; Brinker, K.R.; Dawidson, I.; Dickerman, R.M.; Emerson, W.; Helderman, J.H.; Levitz, B.; Long, D.L.; Nesser, D. 1986: Dallas experience with cyclosporine a (CsA) one to six months posttransplant Transplantation Proceedings 18(2 Suppl 1: 128-131
Wang, M.; Qu, X.; Stepkowski, S.M.; Chou, T.C.; Kahan, B.D. 1996: Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus Transplantation 61(3): 458-464
Schulak, J.A.; Cooke, J.C.; Herrmann, M.J. 1990: Failure of donor irradiation and graft lymph node reduction to prolong pancreas allograft survival in cyclosporine- and donor-specific transfusion-treated hosts Transplantation 50(2): 341-343
Schorn, T.; Frei, U.; Brackmann, H.; Lorenz, M.; Vogt, P.; Wiese, B.; Pichlmayr, R.; Koch, K.M. 1988: Cyclosporine-associated posttransplant hypertension incidence and effect on renal transplant function Transplantation Proceedings 20(3 Suppl 3): 610-614
Salomon, D.; Brunson, M.; Vansickler, J.; Pfaff, W.; Howard, R.; Peterson, J.; Curry, T.; Thompson, R.; Squiers, E. 1991: A retrospective analysis of late renal graft function: correlation with mean cyclosporine levels and lack of evidence for chronic cyclosporine toxicity Transplantation Proceedings 23(1 Pt 2): 1018-1019